Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Weekend – Bulletin Board Heroes, Sunday 25th October 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Weekly Stock Market News, Sunday 16th August 2020
Another busy week in the markets, we are planning several more webinars and will release the registration details soon. We have also rolled out daily updates – these are sent
Share Talk Weekly Stock Market News, 9th August 2020
A busy week at Share Talk, on Tuesday 11th August at 6 pm Share Talk are proud to presents an Investor Webinar and Q & A with Condor Gold PLC.
Dr Adam M Hill, Chief Executive Officer of Oncimmune Holdings (ONC.L) Podcast
Further evidence for the use of the EarlyCDT Lung blood test in lung cancer screening
Share Talk Bulletin Board Heroes, Wednesday 18th March 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Share Talk Bulletin Board Heroes, Wednesday 4th March 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Share Talk Bulletin Board Heroes, Thursday 27th February 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Share Talk Bulletin Board Heroes, Tuesday 18th February 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Oncimmune Holdings plc (AIM:ONC) First tranche of £10M equity investment from Genostics
Oncimmune Holdings plc (AIM:ONC), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® liquid biopsy platform technology, today announces that it has entered into the licence agreement